Cargando…
Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation
BACKGROUND: Genetic testing for pathogenic variants associated with hereditary breast and ovarian cancer risk can improve cancer outcomes through enhanced preventive care in both people with known variants and their biologic relatives. Cascade screening—the process of case-finding in relatives by no...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361690/ https://www.ncbi.nlm.nih.gov/pubmed/35945632 http://dx.doi.org/10.1186/s40814-022-01142-9 |
_version_ | 1784764580078026752 |
---|---|
author | Blasi, Paula R. Scrol, Aaron Anderson, Melissa L. Gray, Marlaine Figueroa Tiffany, Brooks Fullerton, Stephanie M. Ralston, James D. Leppig, Kathleen A. Henrikson, Nora B. |
author_facet | Blasi, Paula R. Scrol, Aaron Anderson, Melissa L. Gray, Marlaine Figueroa Tiffany, Brooks Fullerton, Stephanie M. Ralston, James D. Leppig, Kathleen A. Henrikson, Nora B. |
author_sort | Blasi, Paula R. |
collection | PubMed |
description | BACKGROUND: Genetic testing for pathogenic variants associated with hereditary breast and ovarian cancer risk can improve cancer outcomes through enhanced preventive care in both people with known variants and their biologic relatives. Cascade screening—the process of case-finding in relatives by notifying and inviting them to consider testing—currently relies on the patient to notify their own at-risk relatives. However, many of these relatives never learn they might be at risk. We developed and implemented a new health system-led familial genetic risk notification process where the care team offers to contact at-risk relatives directly. This protocol describes a study to assess the feasibility, acceptability, and limited efficacy of this intervention. METHODS: This feasibility study will use a single-arm, nonrandomized, mixed-methods prospective design. We will enroll two groups of participants: probands and relatives of probands. Eligible probands are currently enrolled Kaiser Permanente Washington (KPWA) members with an upcoming appointment for pre-test genetic counseling for hereditary Lynch syndrome, breast, or ovarian cancer. Eligible relatives, who do not have to be KPWA members, are first-and second-degree relatives of probands. During the appointment with the proband, the genetic counselor will determine whether the proband is appropriate for genetic testing and if so, which relatives might benefit from cascade testing. The genetic counselor then will offer to contact any or all identified relatives directly to discuss genetic risk and testing. The primary outcome of this study is the feasibility of the implemented familial notification process, which we will measure using quantitative and qualitative data on intervention reach, intervention acceptability, and limited efficacy. Analyses will be primarily descriptive and exploratory, with the intent of preparing for a future, larger trial of direct contact interventions. DISCUSSION: Our findings will provide new, foundational evidence for the creation of US-based familial notification systems that directly address logistical and ethical challenges while prioritizing the preferences of patients and families. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40814-022-01142-9. |
format | Online Article Text |
id | pubmed-9361690 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93616902022-08-10 Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation Blasi, Paula R. Scrol, Aaron Anderson, Melissa L. Gray, Marlaine Figueroa Tiffany, Brooks Fullerton, Stephanie M. Ralston, James D. Leppig, Kathleen A. Henrikson, Nora B. Pilot Feasibility Stud Study Protocol BACKGROUND: Genetic testing for pathogenic variants associated with hereditary breast and ovarian cancer risk can improve cancer outcomes through enhanced preventive care in both people with known variants and their biologic relatives. Cascade screening—the process of case-finding in relatives by notifying and inviting them to consider testing—currently relies on the patient to notify their own at-risk relatives. However, many of these relatives never learn they might be at risk. We developed and implemented a new health system-led familial genetic risk notification process where the care team offers to contact at-risk relatives directly. This protocol describes a study to assess the feasibility, acceptability, and limited efficacy of this intervention. METHODS: This feasibility study will use a single-arm, nonrandomized, mixed-methods prospective design. We will enroll two groups of participants: probands and relatives of probands. Eligible probands are currently enrolled Kaiser Permanente Washington (KPWA) members with an upcoming appointment for pre-test genetic counseling for hereditary Lynch syndrome, breast, or ovarian cancer. Eligible relatives, who do not have to be KPWA members, are first-and second-degree relatives of probands. During the appointment with the proband, the genetic counselor will determine whether the proband is appropriate for genetic testing and if so, which relatives might benefit from cascade testing. The genetic counselor then will offer to contact any or all identified relatives directly to discuss genetic risk and testing. The primary outcome of this study is the feasibility of the implemented familial notification process, which we will measure using quantitative and qualitative data on intervention reach, intervention acceptability, and limited efficacy. Analyses will be primarily descriptive and exploratory, with the intent of preparing for a future, larger trial of direct contact interventions. DISCUSSION: Our findings will provide new, foundational evidence for the creation of US-based familial notification systems that directly address logistical and ethical challenges while prioritizing the preferences of patients and families. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40814-022-01142-9. BioMed Central 2022-08-09 /pmc/articles/PMC9361690/ /pubmed/35945632 http://dx.doi.org/10.1186/s40814-022-01142-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Study Protocol Blasi, Paula R. Scrol, Aaron Anderson, Melissa L. Gray, Marlaine Figueroa Tiffany, Brooks Fullerton, Stephanie M. Ralston, James D. Leppig, Kathleen A. Henrikson, Nora B. Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation |
title | Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation |
title_full | Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation |
title_fullStr | Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation |
title_full_unstemmed | Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation |
title_short | Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation |
title_sort | feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361690/ https://www.ncbi.nlm.nih.gov/pubmed/35945632 http://dx.doi.org/10.1186/s40814-022-01142-9 |
work_keys_str_mv | AT blasipaular feasibilityacceptabilityandlimitedefficacyofhealthsystemledfamilialrisknotificationprotocolforamixedmethodsevaluation AT scrolaaron feasibilityacceptabilityandlimitedefficacyofhealthsystemledfamilialrisknotificationprotocolforamixedmethodsevaluation AT andersonmelissal feasibilityacceptabilityandlimitedefficacyofhealthsystemledfamilialrisknotificationprotocolforamixedmethodsevaluation AT graymarlainefigueroa feasibilityacceptabilityandlimitedefficacyofhealthsystemledfamilialrisknotificationprotocolforamixedmethodsevaluation AT tiffanybrooks feasibilityacceptabilityandlimitedefficacyofhealthsystemledfamilialrisknotificationprotocolforamixedmethodsevaluation AT fullertonstephaniem feasibilityacceptabilityandlimitedefficacyofhealthsystemledfamilialrisknotificationprotocolforamixedmethodsevaluation AT ralstonjamesd feasibilityacceptabilityandlimitedefficacyofhealthsystemledfamilialrisknotificationprotocolforamixedmethodsevaluation AT leppigkathleena feasibilityacceptabilityandlimitedefficacyofhealthsystemledfamilialrisknotificationprotocolforamixedmethodsevaluation AT henriksonnorab feasibilityacceptabilityandlimitedefficacyofhealthsystemledfamilialrisknotificationprotocolforamixedmethodsevaluation |